These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2140977)

  • 1. Immunohistochemical study of insulitis induced by multiple low doses of streptozocin in CD-1 mice.
    Iwakiri R; Nagafuchi S; Kounoue E; Nakamura M; Kikuchi M; Nakano S; Niho Y
    Diabetes Res Clin Pract; 1990 Apr; 9(1):75-82. PubMed ID: 2140977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Very-low-dose streptozotocin induces diabetes in insulin promoter-mB7-1 transgenic mice.
    Harlan DM; Barnett MA; Abe R; Pechhold K; Patterson NB; Gray GS; June CH
    Diabetes; 1995 Jul; 44(7):816-23. PubMed ID: 7540575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of thymic immunity and insulitis in the development of streptozocin-induced diabetes in mice.
    Nakamura M; Nagafuchi S; Yamaguchi K; Takaki R
    Diabetes; 1984 Sep; 33(9):894-900. PubMed ID: 6236118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of T cell subsets and class I and class II antigen expression in islet grafts and pancreatic islets of diabetic BioBreeding/Worcester rats.
    Weringer EJ; Like AA
    Am J Pathol; 1988 Aug; 132(2):292-303. PubMed ID: 3135758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of insulitis and diabetes in B cell-deficient mice treated with streptozocin: B cells are essential for the TCR clonotype spreading of islet-infiltrating T cells.
    Kondo S; Iwata I; Anzai K; Akashi T; Wakana S; Ohkubo K; Katsuta H; Ono J; Watanabe T; Niho Y; Nagafuchi S
    Int Immunol; 2000 Jul; 12(7):1075-83. PubMed ID: 10882419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose streptozocin-induced autoimmune diabetes in islet transplantation model.
    Weide LG; Lacy PE
    Diabetes; 1991 Sep; 40(9):1157-62. PubMed ID: 1834505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes.
    Jarpe AJ; Hickman MR; Anderson JT; Winter WE; Peck AB
    Reg Immunol; 1990-1991; 3(6):305-17. PubMed ID: 2132756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study.
    Miyazaki A; Hanafusa T; Yamada K; Miyagawa J; Fujino-Kurihara H; Nakajima H; Nonaka K; Tarui S
    Clin Exp Immunol; 1985 Jun; 60(3):622-30. PubMed ID: 3160515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of streptozocin-induced insulitis and diabetes with lobenzarit in CD-1 mice.
    Iwakiri R; Nagafuchi S
    Diabetes; 1989 May; 38(5):558-61. PubMed ID: 2653927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose streptozotocin induced diabetes in mice. Metabolic, light microscopical, histochemical, immunofluorescence microscopical, electron microscopical and morphometrical findings.
    Cossel L; Schneider E; Kuttler B; Schmidt S; Wohlrab F; Schade J; Bochmann C
    Exp Clin Endocrinol; 1985 Feb; 85(1):7-26. PubMed ID: 3157595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
    Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
    Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of immunosuppression on streptozotocin-induced diabetes in C57BL/KsJ mice.
    Leiter EH; Beamer WG; Shultz LD
    Diabetes; 1983 Feb; 32(2):148-55. PubMed ID: 6219026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotyping of insulitis in control and essential fatty acid deficient mice treated with multiple low-dose streptozotocin.
    Fraser RB; Rowden G; Colp P; Wright JR
    Diabetologia; 1997 Nov; 40(11):1263-8. PubMed ID: 9389417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathymic transplantation of islet antigen affects CD8+ diabetogenic T-cells resulting in tolerance to autoimmune IDDM.
    Baumann EE; Buckingham F; Herold KC
    Diabetes; 1995 Aug; 44(8):871-7. PubMed ID: 7621990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy.
    Qu P; Ji RC; Shimoda H; Miura M; Kato S
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec; 281(2):1326-36. PubMed ID: 15386276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with anti-T-lymphocyte antibodies prevents induction of insulitis in mice given multiple doses of streptozocin.
    Herold KC; Montag AG; Fitch FW
    Diabetes; 1987 Jul; 36(7):796-801. PubMed ID: 3556279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gangliosides prevent insulitis but not islet B cell destruction in low-dose streptozocin-treated mice.
    Papaccio G
    Diabetes Res Clin Pract; 1993 Jan; 19(1):9-15. PubMed ID: 8472624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes induced with low doses of streptozotocin is mediated by V beta 8.2+ T-cells.
    Herold KC; Bloch TN; Vezys V; Sun Q
    Diabetes; 1995 Mar; 44(3):354-9. PubMed ID: 7883124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic influence of the streptozotocin-induced insulitis and hyperglycemia.
    Rossini AA; Appel MC; Williams RM; Like AA
    Diabetes; 1977 Oct; 26(10):916-20. PubMed ID: 143386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
    Goldrath AW; Barber L; Chen KE; Alters SE
    J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.